Proctor And Gamble Defend VapoRub Against Recent Study

Miami, FL (AHN) - The makers of popular cold remedy, Vick's VapoRub, are defending the product after a study came out linking it with airway inflammations that can restrict breathing in infants and toddlers.

Researchers at Wake Forrest University conducted the study after treating an 18-month-old girl who developed severe respiratory problems after her parents applied the product directly under her nose. Proctor and Gamble, the makers of VapoRub, make it clear on the package that the product is not to be used on children under two years of age.

A spokesman for Proctor and Gamble, David Bernens, was quoted in the Washington Post saying one incident involving a child should not lead anyone to conclude that VapoRub is unsafe.

"The product is safe and effective when used as directed," Bernens said.

The Wake Forest study said using VapoRub may stimulate mucus production and airway inflammation, which can cause severe breathing problems in small children.

Even in adults, the product can make people feel better, but does nothing to increase airflow or relieve chest congestion, Dr. Bruce K. Rubin, the study's lead author from the Department of Pediatrics at Wake Forest University School of Medicine, said in a statement.

The American College of Chest Physicians said the use of any over-the-counter medication should not be used on a child unless it is cleared by the family's doctor.

"Parents should consult with a physician before administering any over-the-counter medicine to infants and young children," Dr. James A. L. Mathers, president of the American College of Chest Physicians, said in a statement. "Furthermore, the American College of Chest Physicians and several other health-care organizations have concluded that over-the-counter cough and cold medicines can be harmful for infants and young children and are, therefore, not recommended."